Neuropathic pain (NP) is a significant medical and socioeconomic burden. Epidemiological
surveys have indicated that many patients with NP do not receive appropriate treatment for …

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical
recommendations for pharmacologic management are needed. Systematic literature …

BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease
of the somatosensory system, is a disabling condition that affects approximately two million …

Neuropathic pain (NeP), generated by disorders of the peripheral and central nervous
system, can be particularly severe and disabling. Prevalence estimates indicate that 2% to …

Neuropathic pain, comprising a range of heterogeneous conditions, is often severe and
difficult to manage, and this may result in a chronic condition that negatively affects the …

Randomized, double-blind, placebo-controlled trials on neuropathic pain treatment are
accumulating, so an updated review of the available evidence is needed. Studies were …

Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology
Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology Log in or …

Neuropathic pain encompasses a myriad of painful disease states that are often hard to
treat, especially with one single medication. In the comprehensive treatment of neuropathic …

A number of different treatments for neuropathic pain have been studied, but the literature is
sizable, rapidly evolving, and lacks important information about practical aspects of patient …

Despite an increasing number of available therapies, the treatment of neuropathic pain
remains a major issue. Systematic reviews and meta‐analyses indicate that only a minority …